From: The impact of COVID-19 on gastric cancer surgery: a single-center retrospective study
Clinicopathologic data | PCG(N = 68) M (IQR) orN (%) | CG (N = 41) M (IQR) orN (%) | P |
---|---|---|---|
Admission waiting (day) | 4.5 (2–7.75) | 8.0 (2–20) | 0.006* |
Operation waiting (day) | 3 (2–5) | 7 (5–9) | 0.000* |
Comorbidity | 0.144 | ||
Yes | 46 | 22 | |
No | 22 | 19 | |
Tumor marker | 0.298 | ||
CEA | 2.12 | 1.85 | 0.771 |
AFP | 2.85 | 3.01 | 0.883 |
CA199 | 9.70 | 9.63 | 0.863 |
CA724 | 2.03 | 2.13 | |
Clinical TNM stage | 0.112 | ||
I | 17 | 4 | |
II | 18 | 14 | |
III | 30 | 23 | |
IV | 3 | 0 | |
Hemoglobin | 138.50 (119.25–148.75) | 143.00 (119.50–151.00) | 0.726 |
Chest CT scan | 0.000* | ||
Yes | 24 | 30 | |
No | 44 | 11 |